Endocrine Disruptors in Skincare: What the Evidence Actually Says

An endocrine disruptor is a substance that interferes with the body's hormonal signalling system — the endocrine system — by mimicking, blocking, or altering hormonal activity. This can affect oestrogen, androgen, thyroid, and other hormonal pathways. The concern is real and established for high-dose, long-term exposure: pesticides like DDT, industrial chemicals like PCBs, and certain pharmaceutical drugs are confirmed endocrine disruptors with documented health effects at relevant exposure levels. The controversy is around cosmetic ingredients at real-world use concentrations. Many cosmetic ingredients show endocrine activity in laboratory assays — but laboratory assays typically use concentrations many orders of magnitude higher than what reaches systemic circulation via skin absorption. The gap between "shows activity in a cell culture at high concentration" and "causes endocrine disruption at real-world cosmetic use" is often enormous. This doesn't mean concern is unjustified — it means the question "is this an endocrine disruptor?" needs to be followed by "at what dose, via what route, with what frequency?" before it becomes clinically meaningful.

Oxybenzone (benzophenone-3): The most contested sunscreen ingredient. Detected in blood and urine after topical application. Shows oestrogenic activity in vitro. However, the measured plasma concentrations from topical use are several orders of magnitude below the estimated no-effect level. The EU restricts it to 6% in rinse-off and 2.2% in leave-on products. For daily facial SPF use, realistic exposure is well below the EU limit. For body sunscreen applied to large surface areas frequently (e.g., lifeguards), the calculation is different. Parabens (propyl- and butylparaben specifically): Demonstrate weak oestrogenic activity in vitro and in some animal studies. At concentrations found in cosmetics, the oestrogenic effect is estimated to be 10,000–100,000 times weaker than oestradiol. EU restricts concentrations, particularly in products for young children and in leave-on products. Phthalates (diethyl phthalate, DEP): Used as solvents and fixatives, particularly in fragrance formulations. Some phthalates (DEHP, DBP) are classified as reproductive toxicants in the EU and are prohibited in cosmetics. DEP, still used in fragrance, has a less clear risk profile at cosmetic use levels. Triclosan: Antibacterial agent shown to affect thyroid hormone signalling in animal studies. Now banned or significantly restricted in cosmetics in the EU and US.

The endocrine disruptor conversation in cosmetics is often distorted in both directions — either dismissed entirely ("it's too small an amount to matter") or dramatically overstated ("put nothing on your skin that shows any hormonal activity"). Neither serves consumers well. A more useful framework: 1. Route of exposure matters: Skin absorption is generally less efficient than dietary or inhalational exposure. Ingredients with large molecular weights penetrate poorly. Ingredients in rinse-off formulations have less contact time. 2. Cumulative exposure matters: The "cocktail effect" — exposure to multiple weak endocrine-active substances simultaneously — is a real regulatory concern. The EU's SCCS considers cumulative exposure in its assessments. 3. Life stage matters: Developing foetuses, infants, and pubescent children are more sensitive to endocrine disruption than healthy adults. Pregnancy safety guidelines are more conservative than adult use guidelines, for good reason. 4. Regulatory limits exist for a reason: EU cosmetics regulations on endocrine-active ingredients reflect decades of safety assessment with conservative margins. Products sold legally in the EU are within those margins. Practical conclusion: For the general healthy adult population, the endocrine disruption risk from routine cosmetic use of EU-regulated products is considered minimal by the available evidence. For pregnant users, specific ingredient avoidance (see the pregnancy guide) is warranted. For infants and young children, more conservative product choices are rational.